|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0076 - 0.0082|
|52 Week Range||0.0075 - 0.0500|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 19, 2020 - Nov 20, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ELK CITY, Idaho, December 05, 2022--Therapeutic Solutions International (TSOI) announced today preliminary results of a collaboration with the Veltmeyer Institute for Advanced Therapeutics aimed at providing patients with protocols, products and cells, developed by the Company. As part of the collaboration, the Veltmeyer Institute provided an update on the first three patients treated.
ELK CITY, Idaho, November 28, 2022--Therapeutic Solutions International (TSOI) announced today issuance of United States Patent # 11,504,4101 which in its broadest claim covers:
ELK CITY, Idaho, November 14, 2022--Therapeutic Solutions International (TSOI) announced today new data, licensing, and patent filing on a novel cellular therapy for treatment of Chronic Obstructive Pulmonary Disease (COPD) by its Spin-Off Company Breathe Biologics.